Drug development

#Collaboration #Drug development #Drug discovery #Partnership

Nine collaborations driving drug discovery forward in Q4

Diana Spencer compiles a list of the research partnerships that will have a significant impact on the development of new drugs into 2025. Dutch Oncode Institute and Cancer Research Horizons The Dutch Oncode Institute and Cancer Research Horizons formed a strategic alliance during a recent Dutch economic mission to the… Read More

#Business & Investment #News

#AI / data analytics / healthtech / informatics #Alzheimer's #Automation #Biomarkers #Data automation #Data management #Digital biomarkers #Digitalisation #Drug development #Drug discovery #Genetics / genomics #Mass spectrometry / NMR #Neurodegenerative disorders #Neuroscience

New podcast: The far-reaching impact of drug discovery technology

This is the latest episode of the free DDW narrated podcast, titled “The far-reaching impact of drug discovery technology”, which covers three articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: “Accelerating time to market through digitalisation”, “… Read More

#News

#Cancer research #Drug development #Drug discovery #Immune system #Immunotherapy #Life sciences #Lithuania #Oncology #Start-ups #Tumour biology #Tumours

New podcast: Exciting start-ups and developments in drug discovery

This is the latest episode of the free DDW narrated podcast, titled ‘Exciting start-ups and developments in drug discovery’, which covers two articles written for DDW Volume 24 – Issue 1, Winter 2022/2023. They are called: ‘What Lithuania offers life sciences start-ups’ and ‘… Read More

#News

#Drug development #Investment #Life sciences #Treehill Partners #US government

Expert opinion on life sciences in a Trump/RFK era

Max Baumann, Co-Founder and Head of Execution of Treehill Partners, discusses what investors, drug developers, and the rest of the life science sector can do to prepare for the Trump/RFK era. The arrival of a new US administration generates significant industry-wide speculation and anticipation regarding new policies and agendas that may… Read More

#Business & Investment #Exclusive Content #Opinion

#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #Webinar

Don’t miss out: Last chance to register for the DDW CGT Showcase

Join the DDW Cell & Gene Therapy Showcase on 21 November at 2pm GMT, a free online event hosted by DDW and supported by Benchling, Sartorius, Applied StemCell, and Elegen Bio. In this free online event leading industry figures will outline areas of opportunity in CGT drug discovery and… Read More

#News

#Antibody #Antibody libraries #Drug development #Drug discovery #Monoclonal antibodies

A pioneering approach to biotherapeutic antibody discovery 

This is a paid-for advertorial by BIO-RAD. Immunotherapy has revolutionised cancer treatment, yet the drug discovery process to develop new biotherapeutic antibodies remains arduous. However, significant advances in antibody technology such as phage display have enabled fully human antibodies to be developed from animal-free libraries for just about any antigen. … Read More

#Exclusive Content

Cell and gene therapy
#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #Webinar

Webinar: Overcome the challenges of developing CGTs

Join the DDW Cell & Gene Therapy Showcase on 21 November at 2pm GMT, a free online event hosted by DDW and supported by Benchling, Sartorius, Applied StemCell, and Elegen Bio. In this free online event leading industry figures will outline areas of opportunity in CGT drug discovery and… Read More

#News

#Antigen #Cancer vaccine #Drug development #Drug discovery #Infinitopes #Society of Immunotherapy for Cancer (SITC)

Breakthroughs on cancer vaccine development at SITC 2024 

Infinitopes presented three posters on its cancer vaccine discovery and development strategy, including one that has been recognised as a ‘top 100’ poster presentation, at the Society for Immunotherapy of Cancer (SITC) 2024, held in Houston, US, from 6-10 November.  A spinout from Oxford University, supported by Cancer Research UK (CRUK),… Read More

#Cancer Research #News

#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #Webinar

Register now: Discover areas of opportunity in CGT drug discovery

Join the DDW Cell & Gene Therapy Showcase on 21 November at 2pm GMT, a free online event hosted by DDW and supported by Benchling, Sartorius, Applied StemCell, and Elegen Bio. In this free online event leading industry figures will outline areas of opportunity in CGT drug discovery and… Read More

#News

#4BIO Capital #Drug development #Drug discovery #Investment #Life sciences

New podcast: Investment trends for drug discovery and development

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Owen Smith, Partner at… Read More

#News

#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #Webinar

What will the future bring in cell and gene therapies?

Join the DDW Cell & Gene Therapy Showcase on 21 November at 2pm GMT, a free online event hosted by DDW and supported by Benchling, Sartorius, Applied StemCell, and Elegen Bio. In this free online event leading industry figures will outline areas of opportunity in CGT drug discovery and… Read More

#News

#AI / data analytics / healthtech / informatics #Business #Digital solutions #Digital workflow #Drug development #Drug discovery #EMA #FDA #Marketing #Pharmaceuticals #Regulatory

New podcast: How to streamline regulatory approval

This is the latest episode of the free DDW narrated podcast, titled “How to streamline regulatory approval”, which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Quicker time to regulatory submission through improved data management and The three key stages to… Read More

#News #Regulatory

Concussion brain scan
#Concussion #Drug development #Drug therapy #Oxeia Biopharmaceuticals

New podcast: The unmet critical need for concussion drug therapies

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with CEO of… Read More

#News

Dementia
#Alzheimer's #Drug development #Eli Lilly #Monoclonal antibodies #National Institute for Health and Care Excellence (NICE) #Regulatory

UK’s NICE rejects second disease-modifying therapy for Alzheimer’s 

UK regulator the National Institute for Health and Care Excellence (NICE) has ruled against the use of a second monoclonal antibody for Alzheimer’s disease, just two months after rejecting Eisai’s lecanemab (Leqembi).  NICE concluded that Eli Lilly’s donanemab (Kisunla) only provides a “small benefit”… Read More

#News

#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #Webinar

Register now for DDW’s Cell & Gene Therapy Showcase

Join the DDW Cell & Gene Therapy Showcase, a free online event hosted by DDW and supported by Benchling, Sartorius, Applied StemCell, and Elegen Bio. In this free online event leading industry figures will outline areas of opportunity in CGT drug discovery & development sector as well as highlighting challenges… Read More

#News

#Biotechnology #Clinical trials #Drug development #Fibrotic disease

Calluna Pharma advances lead candidate for fibrotic diseases 

Biotechnology company Calluna Pharma has completed a Phase I clinical study for its lead product candidate targeting inflammatory and fibrotic diseases.  The company’s lead candidate, CAL101, was shown to have a favorable safety, pharmacokinetic (PK) and immunogenicity profile in the Phase I study.  CAL101 is… Read More

#News